Meritage Homes Announces Pricing of Additional $200 million of 6.00% Senior Unsecured Notes Due 2025
Mar 02, 2018 17:24 pm UTC| Business
SCOTTSDALE, Ariz., March 02, 2018 -- Meritage Homes Corporation (NYSE:MTH), a leading U.S. homebuilder, today announced the pricing of $200 million aggregate principal amount of its 6.00% senior unsecured notes due June...
DAT Solutions Wins Silver “Stevie” Award for Customer Service
Mar 02, 2018 17:22 pm UTC| Business
PORTLAND, Ore., March 02, 2018 -- DAT Solutions announced today that the company received a Silver “Stevie” Award for Contact Center of the Year. DAT’s presentation, “A Road to Professional Development, Caring Culture,...
Avtec Launches Consultant Liaison Program
Mar 02, 2018 17:03 pm UTC| Business
ORLANDO, Fla., March 02, 2018 -- Avtec Inc., the leading independent provider of mission-critical consoles, will launch its consultant liaison program during the 2018 International Wireless Communications Expo in...
Mohammed A. Markatia to join Arbitrade Board of Directors
Mar 02, 2018 17:02 pm UTC| Business
NEW YORK, March 02, 2018 -- Arbitrade, a leading Coin / Crypto Currency exchange, has announced the appointment of Mohammed A. Markatia to its Board of Directors. Mr. Markatia, as CEO of 24Seven Technologies, joins...
MarketAxess Announces Monthly Volume Statistics for February 2018
Mar 02, 2018 17:00 pm UTC| Business
Company Reports Record Overall Monthly Trading Volume and Record Monthly Average Daily Trading Volume for Overall Volume, U.S. High-Grade, High-Yield, Emerging Markets, Eurobonds and Open Trading™ NEW YORK, March 02,...
RavenQuest Expands National Presence; Completes Bloomera Acquisition
Mar 02, 2018 17:00 pm UTC| Business
VANCOUVER, British Columbia, March 02, 2018 -- RavenQuest BioMed Inc. (CSE:RQB) (the "RavenQuest") is pleased to announce that it has completed the acquisition of 8649081 Canada Inc. ("Bloomera"), a Markham, Ontario...
Otonomy Announces FDA Approval of OTIPRIO(R) for Acute Otitis Externa
Mar 02, 2018 16:55 pm UTC| Business
SAN DIEGO, March 02, 2018 -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for otology, today announced that the U.S. Food and Drug Administration (FDA)...